Recipharm, a global contract development and manufacturing organization (CDMO), is continuing to build its service offerings in new biologic modalities through the acquisitions of Vibalogics and Arranta Bio. Vibalogics is a virotherapy CDMO for the manufacture of oncolytic viruses, viral vaccines and gene therapies, offering process and analytical development, manufacturing, testing and fill-finish services. Vibalogics is responding to the growing biopharmaceutical industry demand for spec...